Overview
BMC Cancer: Open access journal for cancer research, with 3.4 Impact Factor and 12 days to first decision.
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials. BMC Cancer is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We do not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field. Specific criteria for other article types can be found in the submission guidelines. BMC series - open, inclusive and trusted.
- Journal Impact Factor
- 3.4 (2023)
- 5-year Journal Impact Factor
- 3.8 (2023)
- Submission to first decision (median)
- 12 days
- Downloads
- 7,974,312 (2023)
Latest articles
Journal information
- Electronic ISSN
- 1471-2407
- Abstracted and indexed in
-
- ANVUR
- BFI List
- Baidu
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Chinese Academy of Sciences (CAS) - GoOA
- DOAJ
- Dimensions
- EBSCO
- EMBASE
- Gale
- Google Scholar
- INIS Atomindex
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- PubMedCentral
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information